Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma
C. Li, W.-Y. Lin, H. Rizvi, H. Cai, C. D. McFarland, Z. N. Rogers, M. Yousefi, I. P. Winters, C. M. Rudin, D. Petrov, M. M. Winslow
The paper uses a quantitative platform and statistical methods to map pharmacogenomic responses in lung cancer, revealing complex genotype-specific therapeutic interactions.
bioRxiv · Jan 28, 2020Cancer Biology